18-23544950-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000271.5(NPC1):​c.1947+10G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0088 in 1,415,958 control chromosomes in the GnomAD database, including 670 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0070 ( 107 hom., cov: 27)
Exomes 𝑓: 0.0090 ( 563 hom. )

Consequence

NPC1
NM_000271.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.104

Publications

2 publications found
Variant links:
Genes affected
NPC1 (HGNC:7897): (NPC intracellular cholesterol transporter 1) This gene encodes a large protein that resides in the limiting membrane of endosomes and lysosomes and mediates intracellular cholesterol trafficking via binding of cholesterol to its N-terminal domain. It is predicted to have a cytoplasmic C-terminus, 13 transmembrane domains, and 3 large loops in the lumen of the endosome - the last loop being at the N-terminus. This protein transports low-density lipoproteins to late endosomal/lysosomal compartments where they are hydrolized and released as free cholesterol. Defects in this gene cause Niemann-Pick type C disease, a rare autosomal recessive neurodegenerative disorder characterized by over accumulation of cholesterol and glycosphingolipids in late endosomal/lysosomal compartments.[provided by RefSeq, Aug 2009]
NPC1 Gene-Disease associations (from GenCC):
  • Niemann-Pick disease, type C1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Myriad Women’s Health
  • Niemann-Pick disease type C, adult neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, juvenile neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, late infantile neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, severe early infantile neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, severe perinatal form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 18-23544950-C-G is Benign according to our data. Variant chr18-23544950-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 92702.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00704 (1012/143798) while in subpopulation NFE AF = 0.0104 (660/63298). AF 95% confidence interval is 0.00977. There are 107 homozygotes in GnomAd4. There are 521 alleles in the male GnomAd4 subpopulation. Median coverage is 27. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 107 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPC1NM_000271.5 linkc.1947+10G>C intron_variant Intron 12 of 24 ENST00000269228.10 NP_000262.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPC1ENST00000269228.10 linkc.1947+10G>C intron_variant Intron 12 of 24 1 NM_000271.5 ENSP00000269228.4 O15118-1
NPC1ENST00000591051.1 linkc.1023+10G>C intron_variant Intron 5 of 17 2 ENSP00000467636.1 K7EQ23
NPC1ENST00000540608.5 linkn.1861+10G>C intron_variant Intron 10 of 15 2

Frequencies

GnomAD3 genomes
AF:
0.00704
AC:
1011
AN:
143684
Hom.:
107
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.00127
Gnomad AMI
AF:
0.00708
Gnomad AMR
AF:
0.00270
Gnomad ASJ
AF:
0.00149
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00394
Gnomad FIN
AF:
0.0226
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0104
Gnomad OTH
AF:
0.00358
GnomAD2 exomes
AF:
0.00788
AC:
1923
AN:
244166
AF XY:
0.00797
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00176
Gnomad ASJ exome
AF:
0.000200
Gnomad EAS exome
AF:
0.0000550
Gnomad FIN exome
AF:
0.0257
Gnomad NFE exome
AF:
0.0103
Gnomad OTH exome
AF:
0.00690
GnomAD4 exome
AF:
0.00900
AC:
11455
AN:
1272160
Hom.:
563
Cov.:
26
AF XY:
0.00886
AC XY:
5669
AN XY:
640090
show subpopulations
African (AFR)
AF:
0.00102
AC:
32
AN:
31238
American (AMR)
AF:
0.00170
AC:
73
AN:
42970
Ashkenazi Jewish (ASJ)
AF:
0.000359
AC:
9
AN:
25068
East Asian (EAS)
AF:
0.0000289
AC:
1
AN:
34646
South Asian (SAS)
AF:
0.00476
AC:
390
AN:
81850
European-Finnish (FIN)
AF:
0.0238
AC:
1167
AN:
49066
Middle Eastern (MID)
AF:
0.000916
AC:
5
AN:
5458
European-Non Finnish (NFE)
AF:
0.00995
AC:
9434
AN:
948374
Other (OTH)
AF:
0.00643
AC:
344
AN:
53490
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.602
Heterozygous variant carriers
0
307
613
920
1226
1533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00704
AC:
1012
AN:
143798
Hom.:
107
Cov.:
27
AF XY:
0.00740
AC XY:
521
AN XY:
70358
show subpopulations
African (AFR)
AF:
0.00126
AC:
51
AN:
40346
American (AMR)
AF:
0.00270
AC:
39
AN:
14458
Ashkenazi Jewish (ASJ)
AF:
0.00149
AC:
5
AN:
3364
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4908
South Asian (SAS)
AF:
0.00418
AC:
18
AN:
4310
European-Finnish (FIN)
AF:
0.0226
AC:
226
AN:
10004
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.0104
AC:
660
AN:
63298
Other (OTH)
AF:
0.00355
AC:
7
AN:
1972
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.604
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00454
Hom.:
17
Bravo
AF:
0.00467

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Niemann-Pick disease, type C1 Benign:6
Oct 21, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 17, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Jun 20, 2016
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 10, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NPC1: BS2 -

not specified Benign:3
Feb 22, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.53
DANN
Benign
0.30
PhyloP100
0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71534236; hg19: chr18-21124914; COSMIC: COSV106369640; COSMIC: COSV106369640; API